Anthropic Establishes Secret Lab for Biological Drug Development Trials

Anthropic has established a secret lab in the San Francisco Bay Area to expand the use of AI in drug development research. Eric Kauderer-Abrams, the head of life sciences at Anthropic, confirmed that the lab focuses on practical trials, which is part of the company's efforts to develop treatments for rare diseases. The lab is not solely dedicated to drug discovery but aims to address issues related to diseases that do not receive enough attention from the pharmaceutical industry. One source noted that this step represents limited progress toward Anthropic's ambitions, amid growing public concerns about AI.